1. Home
  2. UNTY vs RGNX Comparison

UNTY vs RGNX Comparison

Compare UNTY & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unity Bancorp Inc.

UNTY

Unity Bancorp Inc.

HOLD

Current Price

$53.12

Market Cap

538.6M

Sector

Finance

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$10.01

Market Cap

418.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNTY
RGNX
Founded
1991
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
538.6M
418.1M
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
UNTY
RGNX
Price
$53.12
$10.01
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$65.00
$28.75
AVG Volume (30 Days)
32.7K
636.4K
Earning Date
04-14-2026
05-05-2026
Dividend Yield
1.23%
N/A
EPS Growth
39.66
18.08
EPS
1.40
N/A
Revenue
N/A
$10,393,000.00
Revenue This Year
$12.14
$51.21
Revenue Next Year
$9.56
$19.08
P/E Ratio
$38.38
N/A
Revenue Growth
N/A
126.48
52 Week Low
$41.67
$7.35
52 Week High
$57.30
$16.19

Technical Indicators

Market Signals
Indicator
UNTY
RGNX
Relative Strength Index (RSI) 49.98 58.98
Support Level $50.54 $7.76
Resistance Level $53.91 $10.65
Average True Range (ATR) 1.20 0.63
MACD -0.01 0.15
Stochastic Oscillator 58.95 57.32

Price Performance

Historical Comparison
UNTY
RGNX

About UNTY Unity Bancorp Inc.

Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. The Company has elected to become a financial holding company pursuant to regulations of the Board of Governors of the Federal Reserve System (the FRB). The Company's primary business is ownership and supervision of the Bank. The Company and the Bank derive a majority of their revenue from net interest income (i.e., the difference between the interest received on loans and securities and the interest paid on deposits and borrowings). The Company, through the Bank, conducts a traditional and community-oriented commercial banking business and services, personal and business checking accounts, time deposits, money market accounts, savings accounts, credit cards, automated teller service, and others.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: